Results 271 to 280 of about 2,636,084 (314)
Some of the next articles are maybe not open access.
Leukotrienes in Cardiovascular Diseases
American Journal of Respiratory and Critical Care Medicine, 2000Cysteinyl-leukotrienes (cys-LTs, LTC4, LTD4,and LTE4) are potent lipid mediators, resulting from the oxidative metabolism of arachidonic acid through the 5-lipoxygenase (5-LO) pathway. They are able to affect all major components of the cardiovascular system: they can constrict small and large vessels, modify cardiac and coronary functions, influence ...
G. Folco +5 more
openaire +3 more sources
Hyperlipidaemia and cardiovascular disease
Current Opinion in Lipidology, 1998Abbreviations Apo: apolipoprotein; CAC: coronary artery calcium; CETP: cholesteryl ester transfer protein; CHD: coronary heart disease; HDL(c): high-density lipoprotein (cholesterol); IMT: intima-media thickness; LDL(c): low-density lipoprotein (cholesterol).Lipoprotein levels remain the primary ...
openaire +5 more sources
Prostaglandins and Cardiovascular Diseases
Annals of Nutrition and Metabolism, 1969In discussion of prostaglandins and cardiovascular diseases attention is directed to the structures of the main prostaglandins biochemical synthesis prostaglandin metabolism and prostaglandins and cardiovascular diseases. In general the favorable influence of polyunsaturated fatty acids on the atherosclerotic process can be explained by means of the ...
openaire +3 more sources
Alcohol and cardiovascular diseases
Expert Review of Cardiovascular Therapy, 2001With respect to cardiovascular disorders, epidemiologic studies support the hypothesis of increased risks among heavy alcohol drinkers and indicate a lower risk among lighter drinkers. Increased cardiovascular risks of heavy drinking include cardiomyopathy, systemic hypertension, supraventricular arrhythmias, hemorrhagic stroke and heart failure that ...
openaire +2 more sources
Perinatal Cardiovascular Disease
Clinics in Perinatology, 2016Shannon E G, Hamrick, Nikhil K, Chanani
openaire +2 more sources
The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030
Lancet, The, 2021Birgit Vogel +2 more
exaly